Back to today’s briefing

Story perspectives

23andMe Launches Discover23: Revolutionizing Drug Research with Genetic Data

1/9/2025

50 9

Summary

Story summary

23andMe has unveiled Discover23, a groundbreaking research initiative that grants biopharma partners access to genetic data from over 15 million participants. Utilizing Lifebit's Trusted Research Environment, this platform safeguards participant privacy while enabling the analysis of 172 million genetic variants and 4.7 billion phenotypic data points, paving the way for innovative drug development and clinical trials.

1 of 1

Story summary

23andMe has unveiled Discover23, a groundbreaking research initiative that grants biopharma partners access to genetic data from over 15 million participants. Utilizing Lifebit's Trusted Research Environment, this platform safeguards participant privacy while enabling the analysis of 172 million genetic variants and 4.7 billion phenotypic data points, paving the way for innovative drug development and clinical trials.